Berita

BEIJING, 18 Mei 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (Lepu medis "), sebuah perusahaan terkemuka global yang berspesialisasi dalam pengembangan, manufaktur, dan pemasaran perangkat dan peralatan medis berteknologi tinggi, Pada 14 Mei menghosting Seminar virtual tentang metode COVID-19 untuk deteksi ”untuk berbagi teori dan praktik terbaik untuk mempromosikan lebih lanjut Pengendalian dan Pencegahan COVID-19 global di Tiongkok dan di seluruh dunia.

The seminar, which included a virtual training session and a virtual visit to Lepu Medical’s headquarters in Beijing, was part of the seven-day “Seminar on COVID-19 Methods For Detection,” sponsored by China’s Ministry of Commerce and organized by Beijing Holley-Cotect Pharmaceuticals Co., Ltd. The seminar aimed to help other countries and regions to control the pandemic by sharing China’s advanced prevention and control experience. 

Diselenggarakan secara virtual melalui video live streaming, seminar tersebut mencakup sesi pertanyaan dan jawaban, berbagi seminar, kunjungan cloud, dan format virtual lainnya. Total 77 peserta, termasuk pekerja medis, staf pemerintah, dan peneliti dalam lembaga penelitian ilmiah dari sembilan negara, termasuk Kenya, Mauritius, Peru, Ukraina, Sri Lanka, Irak, Ethiopia, dan Iran bergabung dengan kuliah dan kunjungan cloud yang diselenggarakan oleh Lepu medis.

During the seminar, Lepu Medical invited Dr. Jing Yu from the Wuhan Hospital of Traditional Chinese and Western Medicine to deliver a training lecture on basic knowledge and practical experiences of SARS-COV-2 detection, antigen rapid tests, and biochemical indicators for diagnosis. The training course covered the closed loop and seamless SARS-COV-2 detection process from sampling, sample transfer, sample receipt, testing, result reporting and medical waste treatment in various settings including medical institutions, communities, mass screening sites and public places. The seminar, which was well-received by attendees, included a question and answer session in which Dr. Jing Yu and representatives from Lepu Medical answered detailed questions on COVID-19 detection methods, and provided best practice advice to attendees. 

Lepu Medical’s Antiantigen Rapid Test Kit (Colloidal Gold imunokromatografi), a simple screening method for COVID-19 that delivers quick results with high negative predictive value (NPV), was held up as an example by Dr. Yu during the training session. The antigen test method, which is non-invasive, simple to use, cost-efficient, convenient, rapid, stable and accurate has shown high sensitivity of 95.06% and high specificity of 99.62% in clinical trials in IPE Center for Clinical Laboratory, a Lepu Medical subsidiary. Results can be quickly retrieved in 15 minutes. Lepu Medical provides both Lepu Professional Antigen test kits for use by medical institutions and Lepu Antigen self-test kits for individual self-test use, to support diverse testing needs. The Lepu Antigen self-test kit is already approved by BfArM and available in Germany. 

“(For the antigen rapid test,) the positive results can be seen in the early stage after the symptoms (emerged) or in the infection,” said Dr. Yu, addressing participant questions raised about test timing and sensitivity during the lively Q&A session following her lecture, “The sensitivity of the antigen detection depends on the prevalence of the virus. The positive rate of the antigen rapid test is useful in the high prevalent area. If the viral load of the sample is high, the sensitivity of the antigen test and PCR test can be the same.  All biomarkers combined together can be the most effective.”

In addition to the Antiantigen Rapid Test Kit (Colloidal Gold imunokromatografi), Lepu Medical offers other comprehensive diagnostic solutions including nucleic acid series products and solutions, which provide standard tests for COVID-19 diagnosis, and neutralization antibody test products to detect the effectiveness of COVID-19 vaccines in the post-pandemic period. Other COVID-19 products and solutions include sample collection kits, manual sample extraction kits, automated sample extractors, nucleic acid test kits, real-time PCR systems for standard clinical nucleic acid diagnostics, and antibody test kits and systems for vaccine effect evaluation.

Lepu Medical has been providing proactive support to control the COVID-19 pandemic from an early stage. In early 2020, during the outbreak in China, Lepu Medical started emergency production of medical equipment supplies and donated more than RMB5 million of personal protective equipment (PPE), medical devices and cash to severely impacted areas. The company also developed an online free medical consulting system “Doctor Lepu” to assist patients remotely while supporting social distancing. Lepu Medical subsidiaries also dispatched volunteers and a medical aid team to the city of Wuhan and provided mass COVID-19 nucleic acid testing in Beijing where the company is headquartered. Lepu Medical’s products were also widely used across China’s hospitals, medical centers and COVID-19 testing sites. These products included Lepu Medical’s automatic PCR analysis system, personal forehead thermometers, pulse oximeters, monitors, electrocardiographs, household oxygen generators and pharmaceutical products.

Sebagai perusahaan global yang mencakup lebih dari 80 negara dan wilayah dengan lebih dari 20 mitra OEM global, Lepu medis telah memanfaatkan jaringan dan sumber daya globalnya dalam penelitian dan pengembangan, manufaktur dan distribusi untuk mendukung upaya di seluruh dunia untuk melawan COVID-19. Berbagai produk terkait perusahaan telah diberi sertifikat CE di Eropa dan disetujui oleh Badan Pengawas Obat dan Makanan AS (FDA), dan didistribusikan ke lebih dari 140 negara untuk melawan pandemi tersebut. Lepu medis telah mendukung pengujian massal reguler di beberapa negara, membantu dalam pembukaan ulang fakultas yang teratur di Austria dengan menyediakan lebih dari 20 juta kit uji anti gen untuk melakukan pengujian nasional mulai bulan Januari 2021. Kit uji cepat anti gen SARS-CoV-2 Lepu, terdaftar di daftar putih Tiongkok untuk ekspor, disertifikasi oleh Institut PEI resmi di Jerman dan diberi persetujuan khusus oleh lembaga Federal Jerman untuk obat-obatan dan perangkat medis (PETERNAKAN) untuk pengujian mandiri.

Upholding the company’s spirit of integrity, quality and scientific innovation, Lepu Medical will continue to focus on combating the COVID-19 pandemic and go above and beyond to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.